ALT5 Sigma Corporation Common Stock (ALTS)

FairStock Score: 40/100 — MIXED

Key Financials

Current Price$0.55
Market Cap$111M
P/E Ratio-0.09
ROE-57.92%
Dividend Yield—%
SectorTechnology

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for businesses that earn good returns on capital and sell at a sensible price. ALT5 Sigma does not fit that description. It provides blockchain-based trading, payment, tokenization and settlement tools, plus a biotechnology segment, with only 15 employees. In fiscal Q1 2026, revenue was $4.7 million while net income was -$271.5 million, a margin of -5,761.74%. The provided revenue growth is -2.83% and profit growth is -999.00%. Trailing free cash flow is -$736.8 million, a FairStock FCF yield of -662.0% against a $111.3 million market cap. Those are not minor accounting blemishes; they are enormous cash drains relative to the enterprise. The balance sheet shows little debt (D/E 0.01), but the FairStock Altman Z-Score of 0.01 signals distress. Returns are negative: ROE -57.92%, ROCE -2.20%. At the 2026-07-16 close, the price was $0.55, near the 52-week low of $0.50 and far below $2.80. The FairStock P/B of 0.06 might suggest a bargain, but with the provided EPS figure of -$5.86, P/E of -0.09, and a Piotroski F-Score of 5/9, the cheapness is questionable. There is no demonstrated durable competitive advantage; no Lynch category can be assigned because there are zero years of filed results. Beta of 2.01 adds volatility. A bargain requires a sound business at a discount. Here the business is deeply unprofitable and cash-hungry. I would need evidence of stable revenue, positive cash generation, and a credible balance sheet before calling this an investment rather than a speculation.

In plain English: ALT5 Sigma sells blockchain-based payment and trading tools and also has a biotechnology segment. The business looks weak: revenue slipped and it lost a huge amount of money in its latest reported quarter. The share price is very low, but the numbers show heavy cash burning, so it is not clearly a cheap healthy business.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-07-16 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer